UTHR Financial Facts

Net income per diluted common share (in dollars per share): 3.5
Income from continuing operations before income taxes: 239.1M
See Full Income Statement

Marketable investments: 79.6M
Other current liabilities: 60.9M
See Full Balance Sheet

United Therapeutics Corp. (UTHR) Earnings

  |   Expand Research on UTHR
Next EPS Date 8/5/26 EPS Growth Rate +12.6%
Average EPS % Beat Rate -5.8% Revenue Growth Rate +1.5%
Average % Move 1-Wk after EPS +3.7% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/5/26 Q226 N/A$7.22 N/A N/A$810.43M N/A N/A N/A
5/6/26 Q126 $5.82$6.99 -$1.17$781.5M$798.85M N/A Details
2/25/26 Q425 $7.70$7.10 +$0.60$790.2M$815.24M N/A Details
10/29/25 Q325 $7.16$7.32 -$0.16$799.5M$812.87M N/A Details
7/30/25 Q225 $6.41$7.35 -$0.94$798.6M$804.98M N/A Details
4/30/25 Q125 $6.63$6.53 +$0.10$794.4M$728.34M N/A Details
2/26/25 Q424 $6.19$6.68 -$0.49$735.9M$739.92M N/A Details
10/30/24 Q324 $6.39$6.53 -$0.14$748.9M$722.95M N/A Details